1,121
Views
0
CrossRef citations to date
0
Altmetric
Brief Report

Lumican modulates adipocyte function in obesity-associated type 2 diabetes

, , , , , , , & ORCID Icon show all
Pages 665-675 | Received 16 Jun 2022, Accepted 29 Nov 2022, Published online: 06 Dec 2022

References

  • Sumińska M, Podgórski R, Bogusz-Górna K et al, , Historical and cultural aspects of obesity: From a symbol of wealth and prosperity to the epidemic of the 21st century. Obes Rev. 2022;23(6):e13440.
  • Kusminski CM, Bickel PE, Scherer PE. Targeting adipose tissue in the treatment of obesity-associated diabetes. Nat Rev Drug Discov. 2016;15(9):639.
  • Baker NA, Muir LA, Washabaugh AR, et al. Diabetes-specific regulation of adipocyte metabolism by the adipose tissue extracellular matrix. J Clin Endocrinol Metab. 2017;102(3):1032–1043.
  • Spencer M, Yao-Borengasser A, Unal R, et al. Adipose tissue macrophages in insulin-resistant subjects are associated with collagen VI and fibrosis and demonstrate alternative activation. Am J Physiol Endocrinol Metab. 2010;299(6):E1016–E1027.
  • Zamarron BF, Mergian TA, Cho KW, et al. Macrophage proliferation sustains adipose tissue inflammation in formerly obese mice. Diabetes. 2017;66(2):392–406.
  • Carruthers NJ, Strieder-Barboza C, Caruso JA, et al. The human type 2 diabetes-specific visceral adipose tissue proteome and transcriptome in obesity. Sci Rep. 2021;11(1):1–13.
  • Juliar BA, Peña B, Taylor MRG, et al. Viscoelastic characterization of diabetic and non-diabetic human adipose tissue. Biorheology. 2020;57(1):1–12.
  • Strieder-Barboza C, Baker NA, Flesher CG, et al. Depot-specific adipocyte-extracellular matrix metabolic crosstalk in murine obesity. Adipocyte. 2020;9(1):189–196.
  • Guzmán-Ruiz R, Tercero‐Alcázar C, Rabanal‐Ruiz Y, et al. Adipose tissue depot-specific intracellular and extracellular cues contributing to insulin resistance in obese individuals. Faseb J. 2020;34(6):7520–7539.
  • Wolff G, Taranko AE, Meln I, et al. Diet-dependent function of the extracellular matrix proteoglycan Lumican in obesity and glucose homeostasis. Mol Metab. 2019;19:97–106.
  • Oliva K, Barker G, Rice GE, et al. 2D-DIGE to identify proteins associated with gestational diabetes in omental adipose tissue. J Endocrinol. 2013;218(2):165–178.
  • Schaefer L, Raslik I, Gröne H-J, et al. Small proteoglycans in human diabetic nephropathy: discrepancy between glomerular expression and protein accumulation of decorin, biglycan, lumican, and fibromodulin. FASEB J. 2001;15(3):559–561.
  • Liu X-J, Kong, FZ, Wang, YH, et al. Lumican accelerates wound healing by enhancing α2β1 integrin-mediated fibroblast contractility. PloS One. 2013;8(6):e67124.
  • Hayashi Y, Call MK, Chikama T-I, et al. Lumican is required for neutrophil extravasation following corneal injury and wound healing. J Cell Sci. 2010;123(17):2987.
  • Seomun Y, Joo C-K. Lumican induces human corneal epithelial cell migration and integrin expression via ERK 1/2 signaling. Biochem Biophys Res Commun. 2008;372(1):221–225.
  • Karamanou K, Perrot G, Maquart F-X, et al. Lumican as a multivalent effector in wound healing. Adv Drug Deliv Rev. 2018;129:344–351.
  • Liu C, Hu Y, Wang Z, et al. The downregulation of placental Lumican promotes the progression of preeclampsia. Reprod Sci. 2021;28(11):3147–3154.
  • Lee J-Y, Kim, DA, Kim, EY, et al. Lumican inhibits osteoclastogenesis and bone resorption by suppressing Akt activity. Int J Mol Sci. 2021;22(9):4717.
  • Lee JY, Park, SJ, Kim, DA, et al. Muscle-derived lumican stimulates bone formation via integrin α2β1 and the downstream ERK signal. Front Cell Dev Biol. 2020;8:565826.
  • Appunni S, Rubens M, Ramamoorthy V, et al. Lumican, pro-tumorigenic or anti-tumorigenic: a conundrum. Clin Chim Acta. 2021;514:1–7.
  • Martinez-Santibañez G, Cho KW, Lumeng CN. Imaging white adipose tissue with confocal microscopy. Methods Enzymol. 2014;537:17–30. Elsevier.
  • Muir LA, Neeley CK, Meyer KA, et al. Adipose tissue fibrosis, hypertrophy, and hyperplasia: correlations with diabetes in human obesity. Obesity (Silver Spring). 2016;24(3):597–605.
  • Baker NA, Muir LA, Lumeng CN, et al. Differentiation and metabolic interrogation of human adipocytes. Methods Mol Biol. 2017;1556:61–76.
  • Vuillermoz B, Khoruzhenko A, D’Onofrio M-F, et al. The small leucine-rich proteoglycan lumican inhibits melanoma progression. Exp Cell Res. 2004;296(2):294–306.
  • D’Onofrio M-F, Brézillon S, Baranek T, et al. Identification of β1 integrin as mediator of melanoma cell adhesion to lumican. Biochem Biophys Res Commun. 2008;365(2):266–272.
  • Kraus NA, Ehebauer F, Zapp B, et al. Quantitative assessment of adipocyte differentiation in cell culture. Adipocyte. 2016;5(4):351–358.
  • Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method. methods. 2001;25(4):402–408.
  • Yamamoto T, Matsuda Y, Kawahara K, et al. Secreted 70 kDa lumican stimulates growth and inhibits invasion of human pancreatic cancer. Cancer Lett. 2012;320(1):31–39.
  • Khan T, Muise ES, Iyengar P, et al. Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI. Mol Cell Biol. 2009;29(6):1575–1591.
  • Mariman ECM, Wang P. Adipocyte extracellular matrix composition, dynamics and role in obesity. P Cell Mol Life Sci. 2010;67(8):1277–1292
  • Molina H, Yang Y, Ruch T, et al. Temporal profiling of the adipocyte proteome during differentiation using a five-plex SILAC based strategy. J Proteome Res. 2009;8(1):48–58.
  • Halberg N, Khan T, Trujillo ME, et al. Hypoxia-inducible factor 1α induces fibrosis and insulin resistance in white adipose tissue. Mol Cell Biol. 2009;29(16):4467–4483.
  • Pilling D, Vakil V, Cox N, et al. TNF-α–stimulated fibroblasts secrete lumican to promote fibrocyte differentiation. Proc Nat Acad Sci. 2015;112(38):11929–11934.
  • Keophiphath M, Achard V, Henegar C, et al. Macrophage-secreted factors promote a profibrotic phenotype in human preadipocytes. Mol Endocrinol. 2009;23(1):11–24.
  • Ruiz-Alcaraz AJ, Lipina C, Petrie JR, et al. Obesity-induced insulin resistance in human skeletal muscle is characterised by defective activation of p42/p44 MAP kinase. PloS One. 2013;8(2):e56928–e56928.
  • Sun K, Tordjman J, Clément K, et al. Fibrosis and adipose tissue dysfunction. Cell Metab. 2013;18(4):470–477.